Sitemap

Serbian Scientist Gordana Vunjak Won European Inventor Award 2021

More...

Evaluating the Public Administration

User experience is very important in developing...

Where Does Your Ice Cream Come From?

In 2020, the EU produced over 2.9 billion litres...

Proposed New Projects For Financing From Investment Framework For Western Balkans

Minister of European Integration and national IPA...

Farewell Reception For Ambassador Sem Fabrizi

Ambassador of Italy to Serbia, H.E. Carlo...

Evaluating the Public Administration

User experience is very important in developing good services. The citizens of Serbia have recently had the opportunity to...

Where Does Your Ice Cream Come From?

In 2020, the EU produced over 2.9 billion litres of ice cream, representing a 9% decline from the previous year. Over the...

Proposed New Projects For Financing From Investment Framework For Western Balkans

Minister of European Integration and national IPA coordinator Jadranka Joksimovic proposed on behalf of the government, within the sixth...

Farewell Reception For Ambassador Sem Fabrizi

Ambassador of Italy to Serbia, H.E. Carlo lo Cascio was the host of the reception in honour of the...

Cooperation Agreement Signed With American Company On Solar Power Plants

Deputy Prime Minister and Minister of Mining and Energy Zorana Mihajlovic signed today, in the presence of President of...

Serbian-American biomedical engineer and university professor Gordana Vunjak-Novakovic won the Award’s Popular Prize, having received the most votes from the public in an online poll. Vunjak-Novakovic, who had been nominated in the “Lifetime achievement” category, opened new horizons in regenerative medicine by developing a way of growing new tissue ex vivo (outside the body) using the patient’s own cells.

Gordana Vunjak-Novakovic opened new horizons in regenerative medicine by developing a way of growing new tissue ex vivo (outside the body) using the patient’s own cells. Vunjak-Novakovic’s ground-breaking approach offers a safer, more precise and less intrusive facial reconstruction method and holds promise for replacing damaged lung and heart tissue.

Traditionally, replacing damaged or missing human tissue has involved using either a painful graft from another part of the patient’s body or donor material from a cadaver, which might be rejected by the patient’s immune system. In both cases, cells are combined with biomaterials before being inserted into the body in the hope that the transplant will find a way to regenerate tissue. This approach also makes it difficult to shape bone – the most common tissue transplant after blood transfusion – into exactly the right shape.

Dissatisfied with earlier methods, Vunjak-Novakovic and her team pioneered an alternative: growing cells in a laboratory, carefully controlling the environment to influence the type of tissue that develops, and thenimplanting this lab-grown tissue into the body. This method works by attaching stem cells to a biomaterial scaffold that serves as a template and determines the type of tissue that will form.The scaffold and stem cells are inserted into a bioreactor that mimics conditions in the human body and carefully controls variables such as temperature, pH, nutrients, oxygen and growth factors. Tissue cultured in this way is anatomically precise and, when implanted into a patient’s body, helps to suppress immune rejection.

An effective solution with unparalleled potential

Vunjak-Novakovic has applied her technology to multiple areas of tissue regeneration and commercialises her patented inventions through several companies, including EpiBone, which she co-founded in 2013. Some two million bone grafts are performed each year, and among the patients are children born with congenital deformations to the head and face. These children would normally have to undergo multiple surgeries over several years since replacement grafts are needed as the child grows. Vunjak-Novakovic’s method removes the need for repeated surgeries as the implanted bone grows with the child.

TARA Biosystems, another company co-founded by Vunjak-Novakovic, has developed a method to engineer human heart tissue. The company provides functioning heart tissue for various biomedical applications, including in vitro testing of new drugs or creating patient-specific tissue to enable personalised diagnosis and treatment. She also co-leads research into the regeneration of badly damaged lungs for transplantation by connecting them to the recipient’s circulatory system before the transplant takes place. Most recently, Vunjak-Novakovic and her colleagues have explored how their technology might repair lung tissue damaged by COVID-19.

Source: epo.org Photo: AndreasHofweber.com

Related Articles

Evaluating the Public Administration

User experience is very important in developing good services. The citizens of Serbia have recently had the opportunity to assess the level of service...

Comment

New Ways To Promote Good

It is time to reflect on the past 30 years of the bilateral cooperation programme and seek new paths of collaboration. Switzerland’s longstanding commitment...

Ambassador Fabrizi Visited The Training Of Serbian Paralympians

Head of the EU Delegation to Serbia, Ambassador Sem Fabrizi, and President of the Paralympic Committee of Serbia, Zoran Micovic, visited today the training of Paralympic athletes...

Significant Progress Of Serbia In Field Of Innovations

The government of the Republic of Serbia announced that the latest report of the European Commission on the evaluation of innovations (European Innovation Scoreboard)...

First Gold Medal For Serbia At The Tokyo Olympics

Serbia won the first gold medal at the Olympic Games in Tokyo! Back in 2012 in London Olympics, we were delighted by taekwondo represetative Milica...

U.S. Department of State: Serbia’s Investment Climate Improving

Serbia’s investment climate has modestly improved in recent years, but bureaucratic delays and corruption continue to pose a challenge, the U.S. Department of State...

ReLOaD 2 – Strengthening The Partnership Between Local Authorities And Civil Society

The second phase of the Regional Programme on Local Democracy in the Western Balkans (ReLOaD2), worth 13.5 million euros, has officially begun and will...

Eur 20 Million Grants For The Development Of Innovation Of Serbian Enterprises

Thanks to the synergetic effect created by the partnership between the Republic of Serbia and the European Union, as well as the orientation of...